Cargando…
Overview of Comprehensive Hepatitis C Virus Medication Management in a State Medicaid Program
BACKGROUND: Breakthrough direct-acting antivirals set a new standard in the management of hepatitis C virus (HCV) with regard to cure rates and improved tolerability; however, the health care system is challenged by the cost of these medications. OBJECTIVE: To describe the effect of a comprehensive...
Autores principales: | Lavitas, Pavel, Tesell, Mark, Hydery, Tasmina, Greenwood, Bonnie C., Price, Mylissa, Lenz, Kimberly, Jeffrey, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398077/ https://www.ncbi.nlm.nih.gov/pubmed/27668564 http://dx.doi.org/10.18553/jmcp.2016.22.10.1161 |
Ejemplares similares
-
Effectiveness of Ledipasvir/Sofosbuvir and Predictors of Treatment Failure in Members with Hepatitis C Genotype 1 Infection: A Retrospective Cohort Study in a Medicaid Population
por: Kouris, George, et al.
Publicado: (2018) -
Prescription digital therapeutics: Applying Medicaid experience to value assessment and formulary management
por: Salsabili, Mahsa, et al.
Publicado: (2023) -
Payer perceptions and use of value assessment tools in the United States
por: Westrich, Kimberly, et al.
Publicado: (2023) -
Access to New Medications for Hepatitis C for Medicaid Members: A Retrospective Cohort Study
por: Clements, Karen M., et al.
Publicado: (2016) -
A Comprehensive Review of Pegvaliase, an Enzyme Substitution Therapy for the Treatment of Phenylketonuria
por: Hydery, Tasmina, et al.
Publicado: (2019)